Search Results - "Fukuhara, Mitsuro"

Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer by Ozaki, Yuki, Muto, Satoshi, Takagi, Hironori, Watanabe, Masayuki, Inoue, Takuya, Fukuhara, Mitsuro, Yamaura, Takumi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Ohsugi, Jun, Hoshino, Mika, Shio, Yutaka, Tanaka, Daisuke, Nanamiya, Hideaki, Imai, Jun-ichi, Isogai, Takao, Watanabe, Shinya, Suzuki, Hiroyuki

“…Cancer treatment using immune checkpoint inhibitors is widely used, although biomarkers predictive of response are not well established. However, both the…”
Get full text

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study by Fukuhara, Mitsuro, Muto, Satoshi, Inomata, Sho, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Watanabe, Masayuki, Inoue, Takuya, Yamaura, Takumi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki

“…Introduction The presence of tertiary lymphoid structure (TLS) in tumor tissues has been reported to be a factor associated with a good prognosis in several…”
Get full text

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung by Takagi, Hironori, Muto, Satoshi, Enta, Akio, Fukuhara, Mitsuro, Asano, Shigeyuki, Shio, Yutaka, Suzuki, Hiroyuki

“…A patient presented with vomiting and gait disturbance. Investigation revealed a single cerebellar tumor and another tumor in the upper lobe of the left lung…”
Get full text

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC by Muto, Satoshi, Inomata, Sho, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Watanabe, Masayuki, Inoue, Takuya, Yamaura, Takumi, Fukuhara, Mitsuro, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki

“…Treatments containing ipilimumab have shown a good outcome in patients with non-small cell lung cancer (NSCLC) regardless of the PD-L1 tumor proportion score…”
Get full text

Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips by Matsumura, Yuki, Fukuhara, Mitsuro, Tanabe, Hayato, Yamaguchi, Hikaru, Takagi, Hironori, Ozaki, Yuki, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Suzuki, Hiroyuki

“…Posterior mediastinal paraganglioma (PM-PGL) is a rare disease that is difficult to diagnose. If PM-PGL is misdiagnosed preoperatively, surgeons may encounter…”
Get full text

Pulmonary Resection for Metastatic Gastric Cancer by Iijima, Yoshihito, Akiyama, Hirohiko, Atari, Maiko, Fukuhara, Mitsuro, Nakajima, Yuki, Kinosita, Hiroyasu, Uramoto, Hidetaka

“…Background: Pulmonary metastasectomy has come to be recognized as an effective treatment for selected patients with some malignancies. On the other hand, the…”
Get full text

FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer by Higuchi, Mitsunori, Owada, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Hasegawa, Takeo, Suzuki, Hiroyuki

“…Nivolumab, an immune checkpoint inhibitor, is recently clinically applied to non-small cell lung cancer (NSCLC) treatment, and this causes T cell activation…”
Get full text

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers by Muto, Satoshi, Enta, Akio, Maruya, Yoshiyuki, Inomata, Sho, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Watanabe, Masayuki, Inoue, Takuya, Yamaura, Takumi, Fukuhara, Mitsuro, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Hamada, Kazuyuki, Suzuki, Hiroyuki

“…Lung cancer is the leading cause of cancer-related deaths worldwide. The standard of care for advanced non-small-cell lung cancer (NSCLC) without driver-gene…”
Get full text

Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature by Hasegawa, Takeo, Ozaki, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Fukuhara, Mitsuro, Yamaura, Takumi, Muto, Satoshi, Okabe, Naoyuki, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki

“…Immune checkpoint inhibitor therapy has changed the standard drug therapy for relapsed or advanced non-small cell lung cancer; its efficacy is well-recognized…”
Get full text

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report by Watanabe, Masayuki, Matsumura, Yuki, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Suzuki, Hiroyuki

“…Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare and highly progressive tumor with a poor prognosis. Although immune checkpoint inhibitors…”
Get full text

Ectopic adrenocorticotropic hormone‐secreting carcinoid with solitary cryptococcosis in the lungs by Takagi, Hironori, Matsumura, Yuki, Fukuhara, Mitsuro, Inomata, Sho, Yamaguchi, Hikaru, Watanabe, Masayuki, Ozaki, Yuki, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Saito, Haruka, Tanabe, Hayato, Shimabukuro, Michio, Suzuki, Hiroyuki

“…Background Carcinoid tumors can on rare occasions ectopically produce adrenocorticotropic hormone (ACTH), causing Cushing's syndrome, and patients could become…”
Get full text

A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib by Matsumura, Yuki, Inomata, Sho, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Watanabe, Masayuki, Ozaki, Yuki, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Hasegawa, Takeo, Shio, Yutaka, Suzuki, Hiroyuki

“…Echinoderm microtubule‐associated protein‐like 4‐anaplastic lymphoma kinase (EML4‐ALK) rearrangements are found in ~ 5% of patients with non‐small cell lung…”
Get full text

Genetic alterations in epidermal growth factor receptor‑tyrosine kinase inhibitor‑na ve non‑small cell lung carcinoma by Yamaura, Takumi, Muto, Satoshi, Mine, Hayato, Takagi, Hironori, Watanabe, Masayuki, Ozaki, Yuki, Inoue, Takuya, Fukuhara, Mitsuro, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki

Get full text

The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial by Inoue, Takuya, Takagi, Hironori, Owada, Yuki, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Yokouchi, Hiroshi, Kanazawa, Kenya, Ohbuchi, Katsuya, Fukushima, Takahisa, Munakata, Mitsuru, Suzuki, Hiroyuki

“…Cisplatin is a key drug in lung cancer therapy. However, cisplatin is also well known to induce gastrointestinal disorders, such as chemotherapy-induced nausea…”
Get full text

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma by Okabe, Naoyuki, Matsumura, Yuki, Yonechi, Athushi, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki, Gotoh, Mitsukazu, Muto, Satoshi, Fukuhara, Mitsuro, Yamaura, Takumi, Watanabe, Yuzuru, Inoue, Takuya, Owada, Yuki, Kimura, Yuka, Osugi, Jun, Hasegawa, Takeo

“…Objective. The aim of this study was to investigate the prognostic value of MicroRNA-210 (miR-210) expression in patients with non-small-cell lung cancer…”
Get full text

Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer by Higuchi, Mitsunori, Takagi, Hironori, Ozaki, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Shio, Yutaka, Suzuki, Hiroyuki

“…Background: According to previous reports, lobectomy with bronchoplasty or angioplasty is a more feasible surgery than pneumonectomy for central-type non-small…”
Get full text

Clinical Features of Endocrine Disorders with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer by Takagi, Hironori, Muto, Satoshi, Fukuhara, Mitsuro, Inomata, Sho, Watanabe, Masayuki, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Shio, Yutaka, Saito, Haruka, Ohe, Keitaro, Iyoda, Tomokazu, Shimabukuro, Michio, Kuroda, Junko, Suzuki, Hiroyuki

“…Immune checkpoint inhibitors(ICIs)could cause immune-related adverse events(irAEs), of which endocrine disorders are relatively common. Symptoms include…”
Get more information

Abnormal branch of right pulmonary artery (A7): a case report and literature review by Atari, Maiko, Nakajima, Yuki, Fukuhara, Mitsuro, Iijima, Yoshihito, Kinoshita, Hiroyasu, Akiyama, Hirohiko, Minamiya, Yoshihiro, Uramoto, Hidetaka

“…In thoracic surgery, anatomic variations of pulmonary artery increase the risks for vessel injury and critical mistakes during pulmonary artery resection. We…”
Get full text

I. History of Immunotherapy and Cancer Vaccine for Lung Cancer by Suzuki, Hiroyuki, Takagi, Hironori, Owada, Yuki, Watanabe, Yuzuru, Inoue, Takuya, Fukuhara, Mitsuro, Yamaura, Takumi, Muto, Satoshi, Okabe, Naoyuki, Hasegawa, Takeo, Shio, Yutaka

Get more information

Exploring the Possibility of New Biomarkers of Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer (NSCLC) by Owada, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Fukuhara, Mitsuro, Yamaura, Takumi, Muto, Satoshi, Matsumura, Yuki, Hasegawa, Takeo, Tanaka, Daisuke, Kanno, Ryo, Ito, Emi, Nanamiya, Hideaki, Imai, Junichi, Isogai, Takao, Watanabe, Shinya, Suzuki, Hiroyuki

“…Mutation burden in a tumor, presumably involving neo-antigens in the tumor tissue, is also thought to be one of the better predictors for the efficacy of…”
Get more information